During the past decade, Instituto Modelo De Cardiología Privado Srl conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto Modelo De Cardiología Privado Srl" are "Pulmonary Arterial Hypertension" (2 trials) and "Chronic Thromboembolic Pulmonary Hypertension" (1 trials). Many other conditions were trialed in "Instituto Modelo De Cardiología Privado Srl" in a lesser frequency.

Most popular intervention types in "Instituto Modelo De Cardiología Privado Srl" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Macitentan" (1 trials), "Macitentan 10 mg" (1 trials), "Macitentan 37.5 mg" (1 trials) and "Macitentan 75 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Modelo De Cardiología Privado Srl" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Modelo De Cardiología Privado Srl". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Instituto Modelo De Cardiología Privado Srl, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Modelo De Cardiología Privado Srl, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".